Small AntiMicrobial Peptide With in Vivo Activity Against Sepsis.

ABSTRACT: Antimicrobial peptides (AMPs) are considered as potential therapeutic sources of future antibiotics because of their broad-spectrum activities and alternative mechanisms of action compared to conventional antibiotics. Although AMPs present considerable advantages over conventional antibiotics, their clinical and commercial development still have some limitations, because of their potential toxicity, susceptibility to proteases, and high cost of production. To overcome these drawbacks, the use of peptides mimics is anticipated to avoid the proteolysis, while the identification of minimalist peptide sequences retaining antimicrobial activities could bring a solution for the cost issue. We describe here new polycationic β-amino acids combining these two properties, that we used to design smal

SUBMITTER: Boullet H 

PROVIDER: S-EPMC6539432 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature